Composition
- Active ingredients
- DEFERASIROX 180MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DEFERASIROX 180MG · TabletThis page
- DEFERASIROX 360MG · TabletNDA206910-003 · Prescription
- DEFERASIROX 90MG · TabletNDA206910-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206910.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Jadenu
- Active substance
- deferasirox
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Novartis Pharms Corp
- Status
- Prescription
- FDA approval
- 30 Mar 2015
- Application
- NDA206910-002